Skip to content

The Effect of Number of Micro-osteo-perforations on the Rate of Tooth Movement.

The Effect of Number of Micro-osteo-perforations on the Rate of Tooth Movement: A Randomized Controlled Trial.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05995509
Acronym
MOPs
Enrollment
30
Registered
2023-08-16
Start date
2023-03-21
Completion date
2024-06-01
Last updated
2023-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthodontic Tooth Movement

Keywords

Micro-osteo-perforations, orthodontic tooth movement, clinical trial

Brief summary

The objective of this split mouth trial is to compare mean canine retraction with one Micro-osteo-perforation (MOP) against three MOPs among Class II division I orthodontic patients after one month of intervention.

Detailed description

One of the main concerns for orthodontists and patients who seek orthodontic therapy is the prolonged treatment time. A commitment of about 18-24 months makes decision making difficult for many patients. The prolonged treatment time is also a potential factor leading to complications like white spot lesions, root resorption, gingivitis and periodontitis. Different techniques to speed up tooth movement have been used in orthodontics. Micro-osteo-perforations is one of the new ways to expedite tooth movement. Previous trials of MOP (Micro-osteo-perforations) to expedite tooth movement had certain shortcomings including the lack of details of randomization. Further studies with variation in the number and frequency of MOPs over a longer duration were recommended. It also raises a curiosity if reducing the number of MOPs would be equally effective in accelerating the canine retraction. Hence, the purpose of this split mouth trial was to investigate the effect of number of MOPs on the rate of canine retraction. The objective of this split mouth trial is to compare mean canine retraction with one MOP against three MOPs among Class II division I orthodontic patients after one month of intervention. STUDY DESIGN: Split-mouth parallel arm randomized control trial.

Interventions

PROCEDUREMicro-osteo-perforations

small perforations drilled in Alveolar bone, adjacent to site of tooth movement.

Sponsors

Gandhara University
CollaboratorOTHER
Rehman Medical Institute - RMI
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
12 Years to 25 Years
Healthy volunteers
Yes

Inclusion criteria

All male and female patients in an age range of 12-25 years requiring bilateral first premolar extraction in maxillary arch. \-

Exclusion criteria

1. Patients with any sort of systemic disease. 2. Radiographic evidence of bone loss. 3. History of periodontal therapy 4. Active periodontal disease. 5. Patients with a history of smoking of five years or more. 6. Patients with active gingivitis and Caries. 7. Attrition of canine cusp.

Design outcomes

Primary

MeasureTime frameDescription
The rate of tooth movement (canine retraction)The movement of canines on both sides will be measured after 30 days of 150g of force application on the intervention and control side.The canine retraction will be measured from a mid-palatine line drawn on the pre treatment and post MOP dental cast. Further perpendicular lines will be drawn towards the distal surface of canine and the mesial surface of the second premolar. The Canine retraction will be measured as the difference between the two lines measured in millimetres. The clinical significance will be set at 50% or more of the rate of canine retraction of the control side.

Secondary

MeasureTime frameDescription
Pain associated with MOPsIn the surgery after the procedure is completed and just before the patient was sent home.The pain or discomfort to the patient will be assessed using a Baker's visual analogue scale on the control and the experimental sides. The scale will be calibrated in millimetres from 0-10 with 0 denoting no pain and 10 denoting worst pain possible.

Countries

Pakistan

Contacts

Primary ContactJavaid
asmjavaid@gmail.com03349590787
Backup ContactSohrab Shaheed, FFDRCSI
s.shaheed@ymail.com03339327608

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026